Fate Therapeutics (FATE) Receivables - Net (2018 - 2025)
Fate Therapeutics (FATE) has disclosed Receivables - Net for 9 consecutive years, with $916000.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net fell 74.12% year-over-year to $916000.0, compared with a TTM value of $916000.0 through Dec 2025, down 74.12%, and an annual FY2025 reading of $916000.0, down 74.12% over the prior year.
- Receivables - Net was $916000.0 for Q4 2025 at Fate Therapeutics, up from $682000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $38.5 million in Q4 2022 and bottomed at $682000.0 in Q3 2025.
- Average Receivables - Net over 5 years is $7.2 million, with a median of $3.8 million recorded in 2024.
- The sharpest move saw Receivables - Net skyrocketed 500.06% in 2021, then tumbled 95.25% in 2023.
- Year by year, Receivables - Net stood at $8.7 million in 2021, then skyrocketed by 343.52% to $38.5 million in 2022, then crashed by 95.25% to $1.8 million in 2023, then skyrocketed by 93.81% to $3.5 million in 2024, then crashed by 74.12% to $916000.0 in 2025.
- Business Quant data shows Receivables - Net for FATE at $916000.0 in Q4 2025, $682000.0 in Q3 2025, and $1.4 million in Q2 2025.